Salman Saif is Head of Corporate Strategic Initiatives & AI at Agomab Therapeutics . He brings 17+ years of experience across biotech and pharma, with leadership roles at argenx, UCB and Baxter spanning R&D strategy, transformation and AI, most recently leading AI Strategy & Roadmap at argenx. He is passionate about how AI can create meaningful value in biotech and pharma, taking a holistic view across business outcomes, operating models, technology and partner ecosystems. Curious by nature, he enjoys exchanging perspectives with leaders across biotech, technology and investment on translating AI’s potential into real-world impact.